1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Bausch & Lomb

Anonymous Board for Bausch & Lomb


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    291
  2. anonymous
    Replies:
    5
    Views:
    1,116
  3. anonymous
    Replies:
    10
    Views:
    911
  4. anonymous
    Replies:
    18
    Views:
    4,458
  5. anonymous
    Replies:
    1
    Views:
    520
  6. anonymous
    Replies:
    6
    Views:
    523
  7. anonymous
    Replies:
    2
    Views:
    547
  8. anonymous
    Replies:
    1
    Views:
    755
  9. anonymous
    Replies:
    1
    Views:
    496
  10. anonymous
    Replies:
    1
    Views:
    475
  11. anonymous
    Replies:
    8
    Views:
    4,116
  12. anonymous
    Replies:
    4
    Views:
    1,367
  13. anonymous
    Replies:
    59
    Views:
    9,194
  14. anonymous
    Replies:
    0
    Views:
    244
  15. anonymous
    Replies:
    0
    Views:
    532
  16. anonymous
    Replies:
    3
    Views:
    1,305
  17. anonymous
    Replies:
    26
    Views:
    4,231
  18. anonymous
    Replies:
    10
    Views:
    2,971
  19. anonymous
    Replies:
    0
    Views:
    445
  20. anonymous
    Replies:
    5
    Views:
    1,184

Thread Display Options

Loading...